Solaris Pharma Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOLARIS PHARMA CORP, and what generic and branded alternatives to SOLARIS PHARMA CORP drugs are available?
SOLARIS PHARMA CORP has five approved drugs.
Summary for Solaris Pharma Corp
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Solaris Pharma Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solaris Pharma Corp | METRONIDAZOLE | metronidazole | GEL;VAGINAL | 213648-001 | Oct 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solaris Pharma Corp | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | GEL;TOPICAL | 212842-001 | Aug 13, 2021 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solaris Pharma Corp | CLINDAMYCIN PHOSPHATE AND TRETINOIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 212845-001 | Feb 10, 2022 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
